The key role of insulin resistance in the cardiometabolic syndrome

Harvinder Gill, Maryann Mugo, Adam Whaley-Connell, Craig S Stump, James R. Sowers

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Insulin resistance is invariably present in patients with the cardiometabolic syndrome and is thought to play a key role in its pathogenesis. It represents a complex interaction of maladaptive characteristics related to impaired insulin action at target organs and external factors such as genetics and environment. It is likely that the molecular factors that underlie insulin resistance and resultant hyperinsulinemia contribute to many of the clinical components of the cardiometabolic syndrome, although the precise associations remain poorly understood. Abnormalities of various adipocytokines (particularly reduced circulating levels of adiponectin and leptin) resistance may also play a role in the genesis of insulin resistance. Genetic factors are an important determinant of insulin sensitivity. Effective management of the cardiometabolic syndrome will ultimately depend on our understanding of the underlying molecular mechanisms of key components of this disorder, such as insulin resistance.

Original languageEnglish (US)
Pages (from-to)290-294
Number of pages5
JournalAmerican Journal of the Medical Sciences
Volume330
Issue number6
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Insulin Resistance
Adipokines
Adiponectin
Hyperinsulinism
Leptin
Insulin

Keywords

  • Adipocytokines
  • Cardiometabolic syndrome
  • Control obesity
  • Genetics
  • Hyperinsulinemia
  • Insulin resistance

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gill, H., Mugo, M., Whaley-Connell, A., Stump, C. S., & Sowers, J. R. (2005). The key role of insulin resistance in the cardiometabolic syndrome. American Journal of the Medical Sciences, 330(6), 290-294.

The key role of insulin resistance in the cardiometabolic syndrome. / Gill, Harvinder; Mugo, Maryann; Whaley-Connell, Adam; Stump, Craig S; Sowers, James R.

In: American Journal of the Medical Sciences, Vol. 330, No. 6, 12.2005, p. 290-294.

Research output: Contribution to journalArticle

Gill, H, Mugo, M, Whaley-Connell, A, Stump, CS & Sowers, JR 2005, 'The key role of insulin resistance in the cardiometabolic syndrome', American Journal of the Medical Sciences, vol. 330, no. 6, pp. 290-294.
Gill, Harvinder ; Mugo, Maryann ; Whaley-Connell, Adam ; Stump, Craig S ; Sowers, James R. / The key role of insulin resistance in the cardiometabolic syndrome. In: American Journal of the Medical Sciences. 2005 ; Vol. 330, No. 6. pp. 290-294.
@article{5fa4361e6c404006a0cc05df9f30cc4b,
title = "The key role of insulin resistance in the cardiometabolic syndrome",
abstract = "Insulin resistance is invariably present in patients with the cardiometabolic syndrome and is thought to play a key role in its pathogenesis. It represents a complex interaction of maladaptive characteristics related to impaired insulin action at target organs and external factors such as genetics and environment. It is likely that the molecular factors that underlie insulin resistance and resultant hyperinsulinemia contribute to many of the clinical components of the cardiometabolic syndrome, although the precise associations remain poorly understood. Abnormalities of various adipocytokines (particularly reduced circulating levels of adiponectin and leptin) resistance may also play a role in the genesis of insulin resistance. Genetic factors are an important determinant of insulin sensitivity. Effective management of the cardiometabolic syndrome will ultimately depend on our understanding of the underlying molecular mechanisms of key components of this disorder, such as insulin resistance.",
keywords = "Adipocytokines, Cardiometabolic syndrome, Control obesity, Genetics, Hyperinsulinemia, Insulin resistance",
author = "Harvinder Gill and Maryann Mugo and Adam Whaley-Connell and Stump, {Craig S} and Sowers, {James R.}",
year = "2005",
month = "12",
language = "English (US)",
volume = "330",
pages = "290--294",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The key role of insulin resistance in the cardiometabolic syndrome

AU - Gill, Harvinder

AU - Mugo, Maryann

AU - Whaley-Connell, Adam

AU - Stump, Craig S

AU - Sowers, James R.

PY - 2005/12

Y1 - 2005/12

N2 - Insulin resistance is invariably present in patients with the cardiometabolic syndrome and is thought to play a key role in its pathogenesis. It represents a complex interaction of maladaptive characteristics related to impaired insulin action at target organs and external factors such as genetics and environment. It is likely that the molecular factors that underlie insulin resistance and resultant hyperinsulinemia contribute to many of the clinical components of the cardiometabolic syndrome, although the precise associations remain poorly understood. Abnormalities of various adipocytokines (particularly reduced circulating levels of adiponectin and leptin) resistance may also play a role in the genesis of insulin resistance. Genetic factors are an important determinant of insulin sensitivity. Effective management of the cardiometabolic syndrome will ultimately depend on our understanding of the underlying molecular mechanisms of key components of this disorder, such as insulin resistance.

AB - Insulin resistance is invariably present in patients with the cardiometabolic syndrome and is thought to play a key role in its pathogenesis. It represents a complex interaction of maladaptive characteristics related to impaired insulin action at target organs and external factors such as genetics and environment. It is likely that the molecular factors that underlie insulin resistance and resultant hyperinsulinemia contribute to many of the clinical components of the cardiometabolic syndrome, although the precise associations remain poorly understood. Abnormalities of various adipocytokines (particularly reduced circulating levels of adiponectin and leptin) resistance may also play a role in the genesis of insulin resistance. Genetic factors are an important determinant of insulin sensitivity. Effective management of the cardiometabolic syndrome will ultimately depend on our understanding of the underlying molecular mechanisms of key components of this disorder, such as insulin resistance.

KW - Adipocytokines

KW - Cardiometabolic syndrome

KW - Control obesity

KW - Genetics

KW - Hyperinsulinemia

KW - Insulin resistance

UR - http://www.scopus.com/inward/record.url?scp=29244436880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244436880&partnerID=8YFLogxK

M3 - Article

C2 - 16355013

AN - SCOPUS:29244436880

VL - 330

SP - 290

EP - 294

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 6

ER -